Home › Compare › VRSCF vs JNJ

VRSCF vs JNJ: Dividend Comparison 2026

VRSCF yields 10582.01% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRSCF wins by $96305188986439456.00M in total portfolio value
10 years
VRSCF
VRSCF
● Live price
10582.01%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$96305188986439456.00M
Annual income
$94,547,588,986,312,240,000,000.00
Full VRSCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VRSCF vs JNJ

📍 VRSCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRSCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRSCF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VRSCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRSCF
Annual income on $10K today (after 15% tax)
$899,470.90/yr
After 10yr DRIP, annual income (after tax)
$80,365,450,638,365,400,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VRSCF beats the other by $80,365,450,638,365,400,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRSCF + JNJ for your $10,000?

VRSCF: 50%JNJ: 50%
100% JNJ50/50100% VRSCF
Portfolio after 10yr
$48152594493219728.00M
Annual income
$47,273,794,493,156,120,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VRSCF
No analyst data
Altman Z
-9.8
Piotroski
0/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRSCF buys
0
JNJ buys
0
No recent congressional trades found for VRSCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRSCFJNJ
Forward yield10582.01% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$96305188986439456.00M ✓$20.0K
Annual income after 10y$94,547,588,986,312,240,000,000.00 ✓$827.78
Total dividends collected$96188342935218304.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VRSCF vs JNJ ($10,000, DRIP)

YearVRSCF PortfolioVRSCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,068,901$1,058,201.06$10,676$355.77+$1.06M → VRSCF
2$106,855,148$105,711,423.45$11,407$389.39+$106.84M → VRSCF
3$9,990,676,194$9,876,341,186.51$12,198$426.53+$9990.66M → VRSCF
4$873,691,903,550$863,001,880,022.38$13,056$467.62+$873691.89M → VRSCF
5$71,467,693,725,507$70,532,843,388,708.38$13,987$513.12+$71467693.71M → VRSCF
6$5,468,584,496,398,291$5,392,114,064,111,998.00$14,998$563.56+$5468584496.38M → VRSCF
7$391,454,428,210,991,600$385,603,042,799,845,440.00$16,098$619.52+$391454428210.98M → VRSCF
8$26,215,485,246,437,097,000$25,796,629,008,251,340,000.00$17,295$681.69+$26215485246437.08M → VRSCF
9$1,642,616,822,548,801,500,000$1,614,566,253,335,114,000,000.00$18,599$750.82+$1642616822548801.50M → VRSCF
10$96,305,188,986,439,450,000,000$94,547,588,986,312,240,000,000.00$20,022$827.78+$96305188986439456.00M → VRSCF

VRSCF vs JNJ: Complete Analysis 2026

VRSCF — Stock

Valterra Resource Corporation, an exploration stage company, engages in the acquisition, exploration, and development of natural resource properties. The company primarily explores for copper, gold, and silver deposits. It holds 100% interests in the Swift Katie property consisting of 19 contiguous MTO mineral claims covering an area of approximately 83 square kilometers located near Salmo, British Columbia; and the Los Reyes property consisting of 2 claims covering an area of approximately 45 hectares located in Chihuahua, Mexico. The company was formerly known as Valterra Wines Ltd. and changed its name to Valterra Resource Corporation to reflect its entry into the mineral resource sector in April 2005. Valterra Resource Corporation was incorporated in 1996 and is headquartered in Vancouver, Canada.

Full VRSCF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VRSCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRSCF vs SCHDVRSCF vs JEPIVRSCF vs OVRSCF vs KOVRSCF vs MAINVRSCF vs ABBVVRSCF vs MRKVRSCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.